Study to enroll 60 participants previously vaccinated with mRNA-1273 in Phase 2, to evaluate booster vaccine candidates against the B.1.351 variant first identified in South Africa ...

After you’ve got the two jabs required for the primary series of the mRNA vaccine, people 6 months or older are eligible for a booster shot 2 months after the last dose. Moderna.

The FDA also authorized a single booster dose of the Moderna COVID-19 Vaccine for individuals who have completed a primary vaccination with other authorized or approved COVID-19 vaccines.

The second arm of Moderna’s omicron booster trial has gotten underway with a first patient dosed in the phase 2 study testing a variant-specific vaccine against COVID-19. The trial is combining ...

U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.

Another study of more than 55,000 long-term care residents in Ontario, Canada, showed a second booster dose of Moderna’s shot increased vaccine effectiveness against infection with omicron ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The reformulated booster doses of the mRNA vaccines from Pfizer/BioNTech and Moderna are “bivalent.” That means they target the original version of SARS-CoV-2 as well as the newer omicron variant.

Moderna MRNA announced that its seasonal influenza vaccine candidate, mRNA-1010, achieved superior relative vaccine efficacy (rVE) than an approved flu shot marketed by GSK plc GSK in a phase III ...

Moderna Inc. stock rose more than 1% in the extended session Wednesday after the biotechnology company said that a single-dose booster COVID-19 vaccine worked against the novel coronavirus ...

Crude incidence rates of CSU following a booster dose in the two cohorts was 1.9-2.1 per 100,000 doses of Pfizer's vaccine and 30.8-43.9 per 100,000 doses of Moderna's product, according to their ...